Price $57.48 |
Market Cap
820.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
26.7
|
P/B
2.89
|
P/S
7.27
|
Dividend %
-
|
|
P/CF
39.4
|
P/FCF
26.4
|
Op. Cash Flow
34K
|
FCF
2.1
|
|
Op. Margin
35.10%
|
Net Margin
27.60%
|
ROE
11.60%
|
ROI
6.50%
|
|
ROA
10.40%
|
EPS Growth
66.10%
|
Current Ratio
18.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Encision Inc (ECIA) | $0.48 | - | - | 5.6M | Strong Buy |
| NantHealth Inc (NH) | $1.10 | - | - | 120.6M | Strong Buy |
| Natus Medical Inc (NTUS) | $31.55 | - | - | 1.11B | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLNF) | $0.74 | - | - | 13.3M | Strong Buy |
| Ocugen Inc (OCGN) | $0.41 | - | - | 5.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
